Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€40.60

€40.60

2.010%
0.8
2.010%
-
 
15:13 / Tradegate WKN: A0YJW7 / Name: Zealand / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Zealand

sharewise wants to provide you with the best news and tools for Zealand, so we directly link to the best financial data sources.

News

Merlin, Inc. Common Stock Q1 Earnings Call Highlights
Merlin, Inc. Common Stock Q1 Earnings Call Highlights

Key Points

SAB Biotherapeutics Q1 Earnings Call Highlights
SAB Biotherapeutics Q1 Earnings Call Highlights

SAB Biotherapeutics (NASDAQ:SABS) said its lead type 1 diabetes candidate, SAB-142, remains on track in a registrational Phase 2b trial, as the

Why Rocket Lab Stock Went to the Moon Today: https://g.foolcdn.com/editorial/images/876761/11252024-close-up-view-if-engine-firing-at-electron-rocket-launch-from-lc-1-in-new-zealand-is-rocket-lab.jpg
Why Rocket Lab Stock Went to the Moon Today

Rocket star Rocket Lab (NASDAQ: RKLB) is making headlines again this morning, after completing yet another satellite launch for Synspective over the weekend. (They also delayed a launch for iQPS,

A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.: https://cdn.content.foolcdn.com/images/1umn9qeh/production/604a69fb7f6ea006ba65d586e735188f5e64c9a9-7089x3988.jpg?w=800&q=75&fit=max&auto=format
A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.

The GLP weight-loss space has become increasingly competitive as new players have entered what many believe is a game-changing new market that’s still in the early innings.

But getting in the game